RedoxBox

RedoxBox is a biotechnology company focused on the development of small molecule therapeutics that target the mitochondrial redox environment to treat age-related diseases. Founded by James Clement, the company builds upon extensive research into the biology of aging and cellular energetics. RedoxBox utilizes a proprietary platform to identify compounds capable of modulating oxidative stress and restoring mitochondrial function, which are central drivers of neurodegeneration and metabolic decline. The company's mission is to translate breakthroughs in longevity science into effective clinical interventions that extend human healthspan. Currently in the pre-clinical stage, RedoxBox is advancing a pipeline of redox-active molecules aimed at fundamental mechanisms of cellular aging.